ASCO24: MAIA Biotechnology touts additional data from NSCLC trial
THIO is a small molecule cancer telomere-targeting agent being investigated in NSCLC, glioblastoma, and other cancers.
Biotechnology
Delivering gene therapy directly to the brain for AADC deficiency
FDA approves first trial investigating CRISPR gene editing as HIV cure
Leading regenerative medicine advocacy group leverages GlobalData’s datasets to highlight a record year
uniQure gene therapy found “highly unlikely” to be cause of liver cancer case
AD/PD 2021: A New Neuro-Regenerative Therapeutic Approach Targeting Protein Kinase C for the Treatment of Alzheimer’s Disease
GSK to expand clinical trial manufacturing capacity at CGT Catapult site in UK
MANTA and MANTA-RAy Safety Readouts Boost Jyseleca’s Prospects in the US
